IP Library Granted Patent US 10,954,557
Granted Patent B2
US 10,954,557 · App. 16/168,002 · Granted Mar 23, 2021

Methods for processing nucleic acid samples

Inventors: Arkadiusz Bibillo (Cupertino, CA); Pranav Patel (Freemont, CA)
Assignee: Bio-Rad Laboratories, Inc.
C12Q1/686C12N9/1276C12N15/1096C12P19/34C12Q1/68C12Q1/6806C12Q1/6846C12Q2600/112C12Q2600/118C12Q2600/158C12Q2600/16C12Q2600/178C12Y207/07049
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,954,557
App. No.
16/168,002
Granted
Mar 23, 2021
Kind
B2
Abstract

The present disclosure provides methods and systems for amplifying and analyzing nucleic acid samples. The present disclosure provides methods for preparing cDNA and/or DNA molecules and cDNA and/or DNA libraries using modified reverse transcriptases.

Claims (32)

1. A method for preparing complementary deoxyribonucleic acid (cDNA), the method comprising:

(a) providing a single vessel comprising an R2 reverse transcription enzyme and one or more template ribonucleic acid molecules; and

(b) in said single vessel, using said R2 reverse transcription enzyme to perform an amplification reaction on said one or more template ribonucleic acid molecules to yield a plurality of complementary deoxyribonucleic acid molecules,

wherein said R2 reverse transcription enzyme comprises one of the following amino acid sequences: SEQ ID NO: 49, SEQ ID NO: 50, SEQ ID NO: 51, SEQ ID NO: 53, SEQ ID NO: 54, SEQ ID NO: 55, SEQ ID NO: 56, SEQ ID NO: 57, SEQ ID NO: 58, SEQ ID NO: 59, SEQ ID NO: 60, SEQ ID NO: 61, SEQ ID NO: 62, SEQ ID NO: 63, SEQ ID NO: 64, SEQ ID NO: 65, SEQ ID NO: 66, and SEQ ID NO: 67.

2. The method of claim 1 , wherein said one or more template ribonucleic acid molecules are from a single cell provided in said single vessel prior to (a).

3. The method of claim 1 , wherein said one or more template ribonucleic acid molecules are present in an amount up to about 100 nM.

4. The method of claim 1 , wherein said R2 reverse transcription enzyme is configured to perform said amplification reaction at a substantially constant temperature.

5. The method of claim 1 , wherein said R2 reverse transcription enzyme is configured to perform said amplification reaction at a temperature of from about 12° C. to about 42° C.

6. The method of claim 1 , wherein said R2 reverse transcription enzyme has a misincorporation error rate of at most about 1 base out of 100 bases.

7. The method of claim 6 , wherein said R2 reverse transcription enzyme has a misincorporation error rate of at most about 1 base out of 10,000 bases.

8. The method of claim 1 , wherein said R2 reverse transcription enzyme is configured to generate said plurality of complementary deoxyribonucleic acid molecules from said one or more template ribonucleic acid molecules with a specific activity of from about 20,000 units/mg to about 140,000 units/mg.

9. The method of claim 1 , wherein said one or more template ribonucleic acid (RNA) molecules comprise messenger RNA, ribosomal RNA, transfer RNA, micro RNA, long non-coding RNA, vault RNA, signal recognition particle RNA, small RNA, small nuclear, small nucleolar RNA, small conditional RNA, amall cajal body-specific RNA, macro long non-protein-coding RNA, long intergenic noncoding RNA, piwi-interacting RNA, small interfering RNA, and ribozymes.

10. The method of claim 1 , wherein said one or more template ribonucleic acid molecules comprise an artificially fragmented ribonucleic acid template, a naturally fragmented ribonucleic acid template, or a combination thereof.

11. The method of claim 1 , wherein using said R2 reverse transcription enzyme to perform the amplification reaction yields the plurality of complementary deoxyribonucleic acid molecules in a time period of less than three hours.

12. The method of claim 1 , wherein said R2 reverse transcription enzyme comprises SEQ ID NO: 49.

13. The method of claim 11 , wherein said R2 reverse transcription enzyme comprises the amino acid sequence of SEQ ID NO: 50.

14. The method of claim 1 , wherein said R2 reverse transcription enzyme comprises the amino acid sequence of SEQ ID NO: 51.

15. The method of claim 1 , wherein said R2 reverse transcription enzyme comprises the amino acid sequence of SEQ ID NO: 53.

16. The method of claim 1 , wherein said R2 reverse transcription enzyme comprises the amino acid sequence of SEQ ID NO: 54.

17. The method of claim 1 , wherein said R2 reverse transcription enzyme comprises the amino acid sequence of SEQ ID NO: 55.

18. The method of claim 1 , wherein said R2 reverse transcription enzyme comprises the amino acid sequence of SEQ ID NO: 56.

19. The method of claim 1 , wherein said R2 reverse transcription enzyme comprises the amino acid sequence of SEQ ID NO: 57.

20. The method of claim 1 , wherein said R2 reverse transcription enzyme comprises the amino acid sequence of SEQ ID NO: 58.

21. The method of claim 1 , wherein said R2 reverse transcription enzyme comprises the amino acid sequence of SEQ ID NO: 59.

22. The method of claim 1 , wherein said R2 reverse transcription enzyme comprises the amino acid sequence of SEQ ID NO: 60.

23. The method of claim 1 , wherein said R2 reverse transcription enzyme comprises the amino acid sequence of SEQ ID NO: 61.

24. The method of claim 1 , wherein said R2 reverse transcription enzyme comprises the amino acid sequence of SEQ ID NO: 62.

25. The method of claim 1 , wherein said R2 reverse transcription enzyme comprises the amino acid sequence of SEQ ID NO: 63.

26. The method of claim 1 , wherein said R2 reverse transcription enzyme comprises the amino acid sequence of SEQ ID NO: 64.

27. The method of claim 1 , wherein said R2 reverse transcription enzyme comprises the amino acid sequence of SEQ ID NO: 65.

28. The method of claim 1 , wherein said R2 reverse transcription enzyme comprises the amino acid sequence of SEQ ID NO: 66.

29. The method of claim 1 , wherein said R2 reverse transcription enzyme comprises the amino acid sequence of SEQ ID NO: 67.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2019
From: 2D GENOMICS INC.
To: BIO-RAD LABORATORIES, INC.
Reel/Frame 049078/0089 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2018
From: BIBILLO, ARKADIUSZ; PATEL, PRANAV
To: 2D GENOMICS INC.
Reel/Frame 047325/0846 →
Continuity (4)
Continuation PCTUS2017061197 · Nov 10, 2017
Provisional Application 62477211 · Mar 27, 2017
Provisional Application 62421028 · Nov 11, 2016
Related Publication 20190040453A1 · Feb 7, 2019